These findings, coupled to our previous observations from our mouse model, suggest that, also in human PDACs, the early activation of DKK3 expression functions as a molecular tumor suppressive event during preneoplastic progression, which diminishes as malignant transformation occurs. The gene discussed is DKK3; the disease is neoplasm.